SEK90.8 -0.2 -0.2%
Last Trade - 8:51am
| Market Cap | £267.8m |
| Enterprise Value | £265.9m |
| Revenue | £55.9m |
| Position in Universe | 632nd / 1827 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 397.6 | 531.5 | 585.1 | 627.2 | 741.6 | 651.6 | 827 | 940 | +10.4% | ||
| +17.3 | +115.7 | -22.3 | -33.2 | -35.8 | +37.1 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
RaySearch Laboratories publ AB is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Public Since | May 29, 1990 |
| No. of Shareholders: | n/a |
| No. of Employees: | 403 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm |
| Shares in Issue | 34,282,773 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Sveavagen 44 Box 3297, STOCKHOLM, 103 65, Sweden |
| Web | http://www.raysearchlabs.com |
| Phone | +46 8 51053000 |
| Contact | () |
| Auditors | Ernst & Young AB |
As of 8:51am, shares in RaySearch Laboratories AB (publ) are trading at SEK90.8, giving the company a market capitalisation of £267.8m. This share price information is delayed by 15 minutes.
Shares in RaySearch Laboratories AB (publ) are currently trading at SEK90.8 and the price has moved by 60.49% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the RaySearch Laboratories AB (publ) price has moved by 21.89% over the past year.
Of the analysts with advisory recommendations for RaySearch Laboratories AB (publ), there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for RaySearch Laboratories AB (publ) is Hold. You can view the full broker recommendation list by unlocking its StockReport.
RaySearch Laboratories AB (publ) is scheduled to issue upcoming financial results on the following dates:
RaySearch Laboratories AB (publ) does not currently pay a dividend.
RaySearch Laboratories AB (publ) does not currently pay a dividend.
RaySearch Laboratories AB (publ) does not currently pay a dividend.
To buy shares in RaySearch Laboratories AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in RaySearch Laboratories AB (publ) are currently trading at SEK90.8, giving the company a market capitalisation of £267.8m.
Here are the trading details for RaySearch Laboratories AB (publ):
Based on an overall assessment of its quality, value and momentum, RaySearch Laboratories AB (publ) is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in RaySearch Laboratories AB (publ) are currently priced at SEK90.8. At that level they are trading at 15.38% discount to the analyst consensus target price of 0.00.
Analysts covering RaySearch Laboratories AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 2.05 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RaySearch Laboratories AB (publ). Over the past six months, the relative strength of its shares against the market has been -9.21%. At the current price of SEK90.8, shares in RaySearch Laboratories AB (publ) are trading at 4.54% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for RaySearch Laboratories AB (publ).
RaySearch Laboratories AB (publ)'s management team is headed by:
Here are the top five shareholders of RaySearch Laboratories AB (publ) based on the size of their shareholding:
